ISA 2020 | MRD Using Multi-Parametric Flow Cytometry in AL Amyloidosis

Andrew Staron, MD, Boston Medical Centre, Boston, MA, discusses the assessment of minimal residual disease (MRD) using multiparametric flow cytometry in treated patients with AL amyloidosis.